[go: up one dir, main page]

ZA200803213B - Formulations of quinolinones - Google Patents

Formulations of quinolinones

Info

Publication number
ZA200803213B
ZA200803213B ZA200803213A ZA200803213A ZA200803213B ZA 200803213 B ZA200803213 B ZA 200803213B ZA 200803213 A ZA200803213 A ZA 200803213A ZA 200803213 A ZA200803213 A ZA 200803213A ZA 200803213 B ZA200803213 B ZA 200803213B
Authority
ZA
South Africa
Prior art keywords
quinolinones
formulations
Prior art date
Application number
ZA200803213A
Inventor
Chou Joyce
Okhamafe Augustus
Frech Patricia
Gullapalli Rampurma
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200803213B publication Critical patent/ZA200803213B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
    • Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
ZA200803213A 2005-11-29 2008-04-11 Formulations of quinolinones ZA200803213B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74057705P 2005-11-29 2005-11-29

Publications (1)

Publication Number Publication Date
ZA200803213B true ZA200803213B (en) 2009-02-25

Family

ID=40107305

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200803213A ZA200803213B (en) 2005-11-29 2008-04-11 Formulations of quinolinones

Country Status (3)

Country Link
CN (1) CN101316593B (en)
TN (1) TNSN08235A1 (en)
ZA (1) ZA200803213B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110031485A (en) * 2008-07-03 2011-03-28 노파르티스 아게 Melt granulation method
AR081776A1 (en) * 2010-06-30 2012-10-17 Novartis Ag PHARMACEUTICAL COMPOSITIONS INCLUDING 4-AMINO-5-FLUORO-3- LACTATE MONOHIDRATE [6- (4-METHYL-PIPERAZIN-1-IL) -1H-BENCIMIDAZOL-2-IL] -1H-QUINOLIN-2-ONA, PROCESS FOR THE COMPOSITION PRODUCTION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05004754A (en) * 2002-11-13 2005-08-02 Chiron Corp Methods of treating cancer and related methods.
EP1682529A4 (en) * 2003-11-07 2010-06-30 Novartis Vaccines & Diagnostic METHODS FOR SYNTHESIS OF QUINOLINONE COMPOUNDS

Also Published As

Publication number Publication date
TNSN08235A1 (en) 2009-10-30
CN101316593A (en) 2008-12-03
CN101316593B (en) 2012-05-02

Similar Documents

Publication Publication Date Title
GB2424581B (en) Formulations
GB2435419B (en) Formulations
EP2046930A4 (en) Rhamnolipid-based formulations
IL190865A0 (en) Formulations of quinolinones
ZA200707654B (en) Formulations
PT2402005T (en) Sustained release formulations of nalbuphine
EP1909584A4 (en) Prenylflavonoid formulations
GB0605780D0 (en) Formulations
GB0718409D0 (en) Formulations
EP1912499A4 (en) Preparation of montelukast
GB0610336D0 (en) Formulations
GB0615108D0 (en) Novel formulations
DK2392335T3 (en) Use of 24-norUDCA
ZA200803213B (en) Formulations of quinolinones
GB0718404D0 (en) Formulations
ZA200807682B (en) Novel formulations
HK1123207A (en) Formulations of quinolinones
GB0500917D0 (en) Novel formulations
GB0504106D0 (en) Novel formulations
GB0522828D0 (en) Novel formulations
GB0500913D0 (en) Novel formulations
GB0519090D0 (en) Novel formulations
GB0500915D0 (en) Novel formulations
GB0500912D0 (en) Novel formulations
GB0526322D0 (en) Formulations